- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

Syncom Formula Standalone September 2025 Net Sales at Rs 121.44 crore, up 19.65% Y-o-Y Syncom Formula Standalone June 2025 Net Sales at Rs 116.55 crore, up 34.22% Y-o-Y Syncom Formula Consolidated ...

Syncom Formulations India (SYFI) has delivered a -27.50% change over the past year, with a 52-week range between 13.09 and 23.46. What Is the Average Daily Trading Volume of Syncom Formulations India ...

Syncom Formulations India declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 13.52% & the profit increased by 68.92% YoY. As compared to the previous quarter, the revenue grew by ...

Syncom Formulations India has a price-to-earnings (P/E) ratio of 23.15 (TTM). This compares to an industry average of 40.58. What is Syncom Formulations India’s price-to-sales ratio? The P/S ratio for ...

Syncom Formulations (India) Limited, a leading name in the Indian pharmaceutical sector specialising in high-quality pharmaceutical formulations, has announced an outstanding performance for the ...

Syncom Formulations (India) Limited is an India-based company that is engaged in the pharmaceutical business. The Company is engaged in the development, manufacturing & sale of pharmaceutical products ...

Get the detailed quarterly/annual income statement for Syncom Formulations (India) Limited (SYNCOMF.NS). Find out the revenue, expenses and profit or loss over the last fiscal year.

The Syncom Formulations India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹15.87 today. What is the Market Cap of Syncom Formulations India Ltd? Market capitalization, short for market cap, ...

View all information regarding the medicines that are manufactured by Syncom Formulations I Ltd. including its generic drug name, trade name, how to use, the price, and its composition.